What You See Is Not Always What You Get


By Catherine Varmazis

Microarray gene expression studies are mainly used in two types of experiments: static and time-series. In fact, in the public domain, time-series experiments account for about 40 percent of the datasets. While time-series experiments are widely used to study biological systems, determining the quality of the results can be a fundamental problem according to Ziv Bar-Joseph, assistant professor of computer science and biological sciences at Carnegie Mellon University. Bar-Joseph is the inventor of a computational method that identifies genes missed by current analysis methods.


Some of the problems involved in the analysis of microarray data include determining the number of replicates for each time point, normalizing across different microarray platforms, and dealing with noise artifacts.


"Even if all these artifacts and noise are perfectly corrected, the resulting time-series profile may not really represent the underlying expression profile," says Bar-Joseph.

Why? One major issue is the sampling rate. In time-series experiments, measurements are taken at different intervals. "If a gene goes up and down in between these intervals, it can be missed even if everything is normalized. You might miss a collection of genes involved in some physiological process or drug response. This is a major issue. This is an error that cannot be caught now even with the most sophisticated normalization tools," says Bar-Joseph.


In addition, different arrest methods used to synchronize cells can cause many genes that are not involved in the system under investigation to react in response to the arrest-and-release treatments. This makes it hard to distinguish between expression profiles that are the result of genes participating in the system and changes stemming from the treatment itself. "The measurements are real in the sense that the genes are going up, but not as a result of the process you're studying, but rather because of the treatment," says Bar-Joseph.


The method Bar-Joseph pioneered aims to solve these problems and see if 'what you see is what you get.' Is what you observe in an expression profile really the way the gene operates in the system?

.

The experimental protocol involves only one additional microarray experiment in which a mixture of cells is profiled throughout the process. The averages/values obtained from this experiment are compared with the time-series profiles. If they agree, one can claim that what you see is what you get. If the time-series profile is higher than the average, one can conclude that the experiment results are a reaction to the treatment or something else unrelated to the process. If the average is high, but the time-series is low, then one can say you missed that gene, perhaps due to sampling problems.


"We did follow-up experiments and chose genes that could not have been identified based on time-series experiments alone, and the method picked them up correctly," says Bar-Joseph.


The program can be downloaded for free at:

http://www.cs.cmu.edu/~zivbj/checksum/checksum.html



Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

gq92112

This Bio•IT World Briefing On “Next-Generation Sequencing,”underwritten by GenomeQuest, Inc.,
presents a selection of feature stories, interviews,commentaries, conference reports, and editorials on the emergence, opportunities, and challenges posed by high-throughput sequencing. Covered in this collection: the launch of new
platforms from Applied Biosystems and Helicos; new applications of nextgen sequencing; the rise of personal genomics; and informatics solutions to vexing problem of managing the vast volumes of next-gen data.  Download now 



sgi_hybrid

SGI's Meeting Today’s Computational Needs for Science

The quest to better understand disease mechanisms and find new treatments is driven by new laboratory technologies and ever-more sophisticated modeling and simulation efforts. As such, life sciences R&D investigations increasingly are relying on more powerful computing resources. The challenge is how to accommodate the broad mix of applications.

Addressing this issue, this paper produced by the Bio-IT World Custom Publishing Group discusses a new SGI Hybrid Computing Environment approach. It optimally uses shared memory systems, multi-processor clusters, and FPGAs to accelerate computational workflows.



sgi_protm

SGI's Supercharging Proteomics Discovery

The deeper study of proteins and their interactions can reveal scientific information once considered nearly untouchable to scientists and researchers. Today, unprecedented advancements in computing power are enabling the creation of mounds of proteomic based data along with the accompanying bottlenecks data can create.

Rather than just “simplify the experiment” to fit the computational resources an alternative is now available with the SGI Proteomics Appliance. This complimentary white paper, produced by the Bio-IT World Custom Publishing Group, looks at ways to use the Proteomic Appliance to handle the most intensive proteomics computing tasks facing science today.



Life Science Webcasts & Podcasts

Waters

Automate Method SOPs for Greater Efficiency and Fewer Errors with Waters® NuGenesis® Intelligent Procedure Manager

waters podcastThe Waters® NuGenesis® SDMS Intelligent Procedure Manager is a workflow software package designed to guide the laboratory analyst through a routine, comprehensive method standard operating procedure (SOP) and integrate results with a chromatography data system. The Intelligent Procedure Manager addresses the predominately manual activities required to perform an analytical method or test, reducing cycle times up to 50-75% as compared to a traditional paper trail with fewer opportunities for human error.  From late-stage development to final product quality control and lot release, Intelligent Procedure Manager can be applied to any lab environment where rigorous adherence to approved test methods and SOPs must be followed, including compliance requirements for cGMP operations. Download Now


More Podcasts

Job Openings

Lilly Singapore Center for Drug Discovery (LSCDD) - Associate Director of Informatics
Lead and mentor a strong team for the Bioinformatics group at the Integrative Computational Sciences (ICS) department at LSCDD towards the development of novel algorithms, data analysis methods and software tools for drug discovery. Work closely with the Software Engineering group at ICS, and collaborate with the Discovery IT organization in Europe and USA. For additional information, or to apply visit: LSCDD 

 Lilly Singapore Center for Drug Discovery (LSCDD) - Senior Software Engineer
Join a strong team of software engineers in our Integrative Computational Sciences (ICS) at LSCDD. Collaborate with, and help develop integrated applications to process and visualize data from cutting-edge technologies used by scientists at Lilly Research Labs (LRL) and the Drug Discovery Research (DDR) teams. The Software Engineering team provides computational tools and tailored software solutions that enable the global effort of Tailored Therapeutics; ‘The Right Drug, at The Right Dose for The Right Patient at The Right Time'. For additional information, or to apply visit: LSCDD 

For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext 100 or via email to bio-itworld@theygsgroup.com.